F2RL3: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 27: | Line 27: | ||
{{GPCR-stub}} | {{GPCR-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 11:40, 17 March 2025
F2RL3 (also known as Proteinase-activated receptor 4) is a protein that in humans is encoded by the F2RL3 gene. This protein is a member of the protease-activated receptor (PAR) family, which is a subfamily of related G protein-coupled receptors (GPCRs).
Function[edit]
F2RL3 is activated by thrombin and trypsin, but not by plasmin or Factor Xa. It is suggested to be involved in platelet activation and regulates angiogenesis in endothelial cells. Thrombin significantly promotes the proliferation and the migration of endothelial cells via the activation of F2RL3.
Clinical significance[edit]
Alterations in the F2RL3 gene have been associated with a variety of diseases, including cancer, cardiovascular disease, and inflammation. Methylation of the F2RL3 gene has been proposed as a potential biomarker for lung cancer and cardiovascular disease risk.
Structure[edit]
The F2RL3 protein is a seven-transmembrane protein, typical of G protein-coupled receptors. The gene encoding this protein is approximately 12 kb in length and is made up of two exons. The sequence of the intron is highly conserved among different species, suggesting a possible functional significance.
See also[edit]
References[edit]
<references />
External links[edit]
- F2RL3 at the National Center for Biotechnology Information
This GPCR-related article is a stub. You can help WikiMD by expanding it.
